These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30482626)

  • 21. Parenchymal Blood Volume Assessed by C-Arm-Based Computed Tomography in Immediate Posttreatment Evaluation of Drug-Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma.
    Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
    Invest Radiol; 2016 Feb; 51(2):121-6. PubMed ID: 26488373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Image quality of arterial phase and parenchymal blood volume (PBV) maps derived from C-arm computed tomography in the evaluation of transarterial chemoembolization.
    Zitzelsberger T; Syha R; Grözinger G; Partovi S; Nikolaou K; Grosse U
    Cancer Imaging; 2018 May; 18(1):16. PubMed ID: 29720249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility of VPCT parameters in the normal pancreas: comparison of two different kinetic calculation models.
    Kaufmann S; Schulze M; Horger T; Oelker A; Nikolaou K; Horger M
    Acad Radiol; 2015 Sep; 22(9):1099-105. PubMed ID: 26112056
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-arm cone-beam CT parenchymal blood volume imaging for transarterial chemoembolization of hepatocellular carcinoma: implications for treatment planning and response.
    O'Donohoe RL; Kavanagh RG; Cahalane AM; Houlihan DD; McCann JW; Ryan ER
    Eur Radiol Exp; 2019 May; 3(1):21. PubMed ID: 31144237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatocellular carcinoma treated with transarterial chemoembolization: dynamic perfusion-CT in the assessment of residual tumor.
    Ippolito D; Bonaffini PA; Ratti L; Antolini L; Corso R; Fazio F; Sironi S
    World J Gastroenterol; 2010 Dec; 16(47):5993-6000. PubMed ID: 21157976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Change in Perfusion Angiography During Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Predicts Short-Term Outcomes.
    Kim HO; Yim NY; Kim JK; Kang YJ; Lee BC; Kim JW
    AJR Am J Roentgenol; 2019 Oct; 213(4):746-754. PubMed ID: 31039020
    [No Abstract]   [Full Text] [Related]  

  • 27. Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.
    Wang Z; Chen R; Duran R; Zhao Y; Yenokyan G; Chapiro J; Schernthaner R; Radaelli A; Lin M; Geschwind JF
    Cardiovasc Intervent Radiol; 2015 Dec; 38(6):1548-56. PubMed ID: 26001366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of contrast-enhanced ultrasonography with a perflubutane-based contrast agent performed one day after transarterial chemoembolization for the early assessment of residual viable hepatocellular carcinoma.
    Takizawa K; Numata K; Morimoto M; Kondo M; Nozaki A; Moriya S; Ishii T; Oshima T; Fukuda H; Okada M; Takebayashi S; Maeda S; Tanaka K
    Eur J Radiol; 2013 Sep; 82(9):1471-80. PubMed ID: 23769188
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
    Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
    [No Abstract]   [Full Text] [Related]  

  • 30. Early response evaluation using CT-perfusion one day after transarterial chemoembolization for HCC predicts treatment response and long-term disease control.
    Tamandl D; Waneck F; Sieghart W; Unterhumer S; Kölblinger C; Baltzer P; Ba-Ssalamah A; Loewe C
    Eur J Radiol; 2017 May; 90():73-80. PubMed ID: 28583650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential dual-phase cone-beam CT is able to intra-procedurally predict the one-month treatment outcome of multi-focal HCC, in course of degradable starch microsphere TACE.
    Lucatelli P; De Rubeis G; Basilico F; Ginanni Corradini L; Corona M; Bezzi M; Catalano C
    Radiol Med; 2019 Dec; 124(12):1212-1219. PubMed ID: 31473930
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can dual-energy CT replace perfusion CT for the functional evaluation of advanced hepatocellular carcinoma?
    Mulé S; Pigneur F; Quelever R; Tenenhaus A; Baranes L; Richard P; Tacher V; Herin E; Pasquier H; Ronot M; Rahmouni A; Vilgrain V; Luciani A
    Eur Radiol; 2018 May; 28(5):1977-1985. PubMed ID: 29168007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-arm Lipiodol CT in transcatheter arterial chemoembolization for small hepatocellular carcinoma.
    Li JJ; Zheng JS; Cui SC; Cui XW; Hu CX; Fang D; Ye LC
    World J Gastroenterol; 2015 Mar; 21(10):3035-40. PubMed ID: 25780303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Histogram Analysis of CT Perfusion of Hepatocellular Carcinoma for Predicting Response to Transarterial Radioembolization: Value of Tumor Heterogeneity Assessment.
    Reiner CS; Gordic S; Puippe G; Morsbach F; Wurnig M; Schaefer N; Veit-Haibach P; Pfammatter T; Alkadhi H
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):400-8. PubMed ID: 26216725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of texture analysis in evaluating liver cancer recurrence after transarterial chemoembolization].
    Wang R; Yang XY; Wang KY; Wang S; Li Q; Wu JF; Xu HT; Dai Y; Han CP; Xu K; Chen GH
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):200-204. PubMed ID: 28482407
    [No Abstract]   [Full Text] [Related]  

  • 36. Multimodality 3D Tumor Segmentation in HCC Patients Treated with TACE.
    Wang Z; Chapiro J; Schernthaner R; Duran R; Chen R; Geschwind JF; Lin M
    Acad Radiol; 2015 Jul; 22(7):840-5. PubMed ID: 25863795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging Hepatocellular Carcinoma with Dynamic CT Before and After Transarterial Chemoembolization: Optimal Scan Timing of Arterial Phase.
    Saake M; Lell MM; Eller A; Wuest W; Heinz M; Uder M; Schmid A
    Acad Radiol; 2015 Dec; 22(12):1516-21. PubMed ID: 26411380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-arm computed tomography parenchymal blood volume measurement in evaluation of hepatocellular carcinoma before transarterial chemoembolization with drug eluting beads.
    Syha R; Grözinger G; Grosse U; Maurer M; Zender L; Horger M; Nikolaou K; Ketelsen D
    Cancer Imaging; 2015 Dec; 15():22. PubMed ID: 26715200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma.
    Du F; Jiang R; Gu M; He C; Guan J
    Radiol Med; 2015 Aug; 120(8):690-4. PubMed ID: 25698303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose volume perfusion computed tomography (VPCT) for diagnosis of solitary pulmonary nodules.
    Sun Y; Yang M; Mao D; Lv F; Yin Y; Li M; Hua Y
    Eur J Radiol; 2016 Jun; 85(6):1208-18. PubMed ID: 27161072
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.